TECHWIRE 30
(CIX: WRAL30)  1,163.64  down arrow-16.27  (-1.38 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: Apple)  124.43  down arrow-1.94  (-1.54 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NY: QUINTILES)  66.97  down arrow-1.03  (-1.51 %)  Updated: 06:40 PM EDT, Mar 31 2015
(OP: BASF SE)  99.47  down arrow-2.74  (-2.68 %)  Updated: 05:20 PM EDT, Mar 31 2015
(NQ: BioCryst)  9.03  up arrow+0.46  (5.37 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: BioDelivery)  10.50  down arrow-0.01  (-0.1 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: CEMP)  34.31  down arrow-0.62  (-1.78 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: Cisco Systems)  27.53  down arrow-0.13  (-0.45 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: Cree)  35.49  up arrow+0.09  (0.24 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: DARA)  0.73  down arrow-0.03  (-3.83 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NY: EMC CORPORATION)  25.56  up arrow+0.04  (0.16 %)  Updated: 06:40 PM EDT, Mar 31 2015
(NQ: Extreme Networks)  3.16  up arrow+0.01  (0.32 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: FB)  82.22  down arrow-0.98  (-1.18 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NY: GLAXOSMITHKLINE)  46.15  down arrow-1.05  (-2.22 %)  Updated: 06:40 PM EDT, Mar 31 2015
(NQ: GOOG)  548.00  down arrow-4.03  (-0.73 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NY: IBM)  160.50  down arrow-2.17  (-1.33 %)  Updated: 06:40 PM EDT, Mar 31 2015
(NY: LH)  126.09  down arrow-1.19  (-0.93 %)  Updated: 06:40 PM EDT, Mar 31 2015
(OP: Lenovo Group)  29.15  up arrow+0.18  (0.62 %)  Updated: 05:20 PM EDT, Mar 31 2015
(NY: MRK)  57.48  down arrow-0.86  (-1.47 %)  Updated: 06:40 PM EDT, Mar 31 2015
(NQ: Microsoft Corp)  40.66  down arrow-0.31  (-0.74 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: NTAP)  35.46  up arrow+0.08  (0.23 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NY: NOVARTIS AG)  98.61  down arrow-2.7  (-2.67 %)  Updated: 06:40 PM EDT, Mar 31 2015
(OP: Novozymes A/S)  45.68  down arrow-1.01  (-2.16 %)  Updated: 05:20 PM EDT, Mar 31 2015
(NY: PFIZER)  34.79  down arrow-0.21  (-0.6 %)  Updated: 06:40 PM EDT, Mar 31 2015
(NQ: Pozen)  7.72  up arrow+0.03  (0.39 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NY: RED HAT)  75.75  down arrow-0.94  (-1.23 %)  Updated: 06:40 PM EDT, Mar 31 2015
(NQ: BBRY)  8.93  up arrow+0.13  (1.48 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: Salix)  172.81  up arrow+0.16  (0.09 %)  Updated: 08:10 PM EDT, Mar 31 2015
(NQ: SQI)  16.93  down arrow-0.4  (-2.31 %)  Updated: 08:10 PM EDT, Mar 31 2015

Posts tagged “Local Firms”

Updated 2:50 p.m. today

Praise for SciQuest; BDSI shares tumble; Scynexis loss; Amazon's referrals; PlayStation gets Spotify

Bulldog In today's Bulldog wrapup of technology and life science news: SciQuest receives good news from a research firm; BDSI stop drops 24 percent on drug trial news; Scynexis posts a $4.2 million loss; Amazon launches its own referral service; and the PlayStation network embraces Spotify.

Updated 9:04 a.m. today

Quintiles forming joint venture to take on LabCorp in clinical trial services

Quintiles          Quintiles, the world's largest life sciences services company, is teaming up with Quest Diagnostics to form a joint venture that will provide clinical trial laboratory services. The new group will be taking on Burlington-based LabCorp, which is the largest provider.

9:02 a.m. today

Premium Lock So why did Quintiles form a joint venture to take on LabCorp?

DNA      Quintiles, the world's largest life science services company, is going to get even bigger - but through a joint venture rather than an acquisition. The deal announced Tuesday to partner with Quest to take on No. 1 lab tester LabCorp is seen as the best way for Quintiles to capitalize on a changing market, a Q executive explains.

Updated 8:31 a.m. today

Government to pay Durham firm $12M for Ebola drug development

Ebola Durham-based BioCryst Pharmaceuticals is receiving $12 million from the federal government to fund further development of a possible drug to treat the deadly Ebola virus. Two vaccines are currently being tested in Africa, but no effective treatment exists.

Updated 11:20 a.m. yesterday

Dermatology drug firm Novan raises $50M in new financing

Novan Therapeutics Novan Therapeutics, which is focused on development of new dermatology products, has closed on $50 million in new financing. The company lands a new investor and also adds two life science executives to its board.

Updated 6:35 a.m. yesterday

Deep dive on Obama's new Broadband Opportunity Council

The Broadband Report       The Broadband Report: The president officially launched a new broadband council last week with the goal of increasing investments in high-speed connectivity and lowering deployment barriers.

6:28 a.m. yesterday

WTW in review: Last week's headline news (Part 1)

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week. We published so many stories last week, we had to post this in two parts.

6:19 a.m. yesterday

WTW in review: Last week's headline news (Part 2)

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week. We published so many stories last week, we had to post this in two parts.

Updated March 27

CoLucid Pharma leaves RTP; Cree LEDs for rural areas; new Samsung, HTC phones; 'Voice'-like app; PayPal's fine

Bulldog In today's Bulldog wrapup of technology and life science news: CoLucid Pharmaceuticals leaves the Triangle; Cree targets rural areas with new LEDs; new Samsung and HTC phones coming April 10; a new "American Idol"- or "Voice"-like app launches; and PayPal pays $7.7 fine.

Updated March 26

Red Hat sizzles: Stock soars to 2nd highest all-time price

Red Hat      Shares in Red Hat haven't been this hot since the go-go days of the "dot com" boom when the company went public and its shares soared to $105. On Thursday, shares soared 11 percent to a new 52-week high of $76.70 after a strong earnings report on Wednesday. And Wall Street analysts are impressed.

March 26

Forbes: Quintiles, SAS, Citrix, Google, UNC Health among top employers

Forbes  In a survey of 20,000 American workers, several technology and life science companies as well as other employers with strong North Carolina connections crack the top ranks of "Forbes' "America's Best Employers" list. Among them: Quintiles, SAS, Citrix, Google, Apple as well as three health systems and two universities.

Updated March 26

Red Hat continues earnings run, to buy back $500M in shares

Jim Whitehurst Red Hat again exceeded Wall Street expectations, reporting fourth-quarter 2014 earnings of $48 million, or 26 cents a share, compared with $45 million, or 24 cents a share in the year ago quarter. The Hatters also announced a $500 million stock buyback program.

March 26

Premium Lock Inside Red Hat earnings: New products add power, revenue to arsenal

Red Hat's latest earnings report on Wednesday demonstrates the broadening reach of the Hatters' open-source based wealth of products with new offerings helping boost revenue for the 52nd consecutive quarter. Technology Business Research Analyst Andrew Smith provides an in-depth analysis.

Red Hat's open cloud solution vs. "closed" Red Hat's open cloud solution vs. "closed"

Updated March 25

Google Fiber expands; Jim Goodnight's venture play; non-GMO food label; new Instagram app; GSK's next HQ in Asia

Bulldog Bulletin In today's Bulldog wrapup of technology and life science news: Google Fiber is expanding; Jim Goodnight's new venture play is biotech; a proposed label for non-GMO foods; Instagram has a new app; and GSK is building a new Asian headquarters.

March 25

Life beyond GSK: The entrepreneurial career options

Biotech   At an event put on by the North Carolina Biotechnology Center and supported by GlaxoSmithKline, more than 300 people who are losing their jobs at GSK through layoffs gathered to hear about possible options for future employment. "There is life beyond GSK," former GlaxoWellcome CEO Robert Ingram tells the crowd.

Updated March 25

Premium Lock Red Hat earnings: Another surprise or will strong dollar wreak havoc?

Surprising Wall Street on earnings report day has become quite the habit at Red Hat. But will the Hatters have a disappointing surprise this afternoon when they report how business went in the last quarter? Analysts and media have plenty of ideas and speculation. If Oracle's earnings are an indicator, currency could play a big role.

Red Hat's shares over past year Red Hat's shares over past year

Updated March 23

Glaxo plans 180 layoffs in Durham

GSK's HQ in London GlaxoSmithKline notified the state Monday that it plans to eliminate 180 jobs at its Durham offices effective June 1.

Tags: Layoffs, GSK
March 23

Biogen drops Idec from name, says change reflects drug firm's focus

Biogen is going back to its roots, changing the company's name after being known as Biogen Idec since 2003. The change reflects the focus of the company now vs. when it merged with Idec in 2003.

New sign at Biogen's RTP campus New sign at Biogen's RTP campus

March 23

Latest news on broadband and telecom options, wireless, E-Rate and NBP turns 5

The Broadband Report       The Broadband Report: Here is a roundup of broadband and telecommunications stories making headlines this week including The New York Times Editorial Board commenting on more and better telecom options; NTCA and Vantage Point release report on why wireless broadband is not a viable substitute for wireline broadband; the FCC has extended the new E-Rate filing deadline to April 16, and FCC Chairman talks about the fifth anniversary of the National Broadband Plan.

March 23

WTW in review: Last week's headline news (Part 1)

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week. We published so many stories last week, we had to post this in two parts.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith